Guideline for the first‐line management of Classical Hodgkin Lymphoma—A British Society for Haematology guideline

GA Follows, SF Barrington, KS Bhuller… - British journal of …, 2022 - Wiley Online Library
This guideline was compiled according to the British Society for Haematology (BSH) process
at BSH Guidelines Process 2016 (b‐s‐h. org. uk). The Grading of Recommendations …

FDG-PET Imaging for Hodgkin and Diffuse large B-cell lymphoma—An updated overview

CA Voltin, J Mettler, J Grosse, M Dietlein, C Baues… - Cancers, 2020 - mdpi.com
Since the mid-1990s, 18F-fluorodeoxglucose (FDG)-positron emission tomography (PET) in
combination with computed tomography has come to play a prominent role in the …

Time to prepare for risk adaptation in lymphoma by standardizing measurement of metabolic tumor burden

SF Barrington, M Meignan - Journal of Nuclear Medicine, 2019 - Soc Nuclear Med
Increased tumor burden is associated with inferior outcomes in many lymphoma subtypes.
Surrogates of tumor burden that are easy to measure, such as the maximum tumor …

Application of the Lugano classification for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the ProLog consensus …

F Ricard, B Cheson, S Barrington… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Our objective was to provide consensus recommendations from a consortium of academic
and industry experts in the field of lymphoma and imaging for consistent application of the …

[HTML][HTML] Quantitative PET-based biomarkers in lymphoma: getting ready for primetime

JP Alderuccio, RA Kuker, F Yang… - Nature Reviews Clinical …, 2023 - nature.com
The use of functional quantitative biomarkers extracted from routine PET–CT scans to
characterize clinical responses in patients with lymphoma is gaining increased attention …

European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours

C Nanni, C Kobe, B Baeßler, C Baues… - The Lancet …, 2023 - thelancet.com
Given the paucity of high-certainty evidence, and differences in opinion on the use of
nuclear medicine for hematological malignancies, we embarked on a consensus process …

The role of PET in first-line treatment of Hodgkin lymphoma

J Trotman, SF Barrington - The Lancet Haematology, 2021 - thelancet.com
PET using 18 F-fluorodeoxyglucose is central to the management of patients with Hodgkin
lymphoma, and PET-adapted strategies have facilitated major improvements in overall …

Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic information

R Nakajima, AJ Moskowitz, L Michaud… - Blood …, 2020 - ashpublications.org
In follicular lymphoma (FL), detection of bone marrow (BM) involvement (BMI) by 18F-
fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) …

PET/MRI improves management of children with cancer

L Baratto, KE Hawk, J Qi, S Gatidis, L Kiru… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Integrated PET/MRI has shown significant clinical value for staging and restaging of children
with cancer by providing functional and anatomic tumor evaluation with a 1-stop imaging test …

The value of routine bone marrow examination in patients with extranodal NK/T‐cell lymphoma staged with PET/CT

Y Yang, JJ Wang, RZ Zhao, C Huang, GQ Shi… - Cancer, 2022 - Wiley Online Library
Background Limited evidence supports the omission of routine bone marrow (BM)
examination (biopsy and aspiration) in patients with nasal‐type extranodal NK/T‐cell …